Early Versus Late Use of Hi-VNI in Covid-19
The Outcome of Early Use of High-velocity Nasal Insufflation in Acute Respiratory Failure Complicating Covid-19
1 other identifier
observational
30
1 country
1
Brief Summary
This study evaluate early administration of high-velocity nasal insufflation in COVID-19 patients presented with acute respiratory failure after failure of conventional low flow nasal cannula bypassing the escalating step of Non re-breathing mask where early use of High velocity nasal insufflations achieved better improvement of respiratory distress, lower oxygen requirements and shorter ICU stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedFirst Submitted
Initial submission to the registry
December 20, 2022
CompletedFirst Posted
Study publicly available on registry
December 23, 2022
CompletedDecember 23, 2022
December 1, 2022
5 months
December 20, 2022
December 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improved oxygenation
Patients with early use of Hi-VNI had better improvement of oxygenation than those with late use of Hi-VNI
through the study completion, average 6 months
Study Arms (2)
Early Hi-VNI
Group 1 of early shift to Hi-VNI after nasal cannula
Late Hi-VNI
Group 2 of late use of Hi-VNI after NRM
Eligibility Criteria
Patients diagnosed as COVID-19 presented with respiratory failure and admitted to intensive care of COVID-19 zone, chest Department, Assiut University hospital, Patients who failed on either low flow nasal cannula or non-rebreathing mask were shifted to Hi-VNI device using a Precision flow vapotherm (vapotherm, Inc, 100 Domain device Exeter, NH 03833, T: 603-658-0011, USA). Patients were classified into 2 groups: Early and late Hi-VNI groups according to whether the shift to Hi-VNI occurred after low flow nasal cannula or non-rebreathing mask respectively.
You may qualify if:
- severe COVID Patients with hypoxemic respiratory failure. 2- Patients with no comorbidities
You may not qualify if:
- Non severe COVID Patients
- Patients with comorbidities (e.g chronic chest dis, DM, renal failure and hepatic failure
- Patients indicated for mechanical ventilation
- Patients with marked hypercapnia in need for non-invasive ventilation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assiut Universitylead
- Aswan Universitycollaborator
Study Sites (1)
Assiut University
Asyut, 71111, Egypt
Related Publications (2)
Granton D, Chaudhuri D, Wang D, Einav S, Helviz Y, Mauri T, Mancebo J, Frat JP, Jog S, Hernandez G, Maggiore SM, Hodgson CL, Jaber S, Brochard L, Trivedi V, Ricard JD, Goligher EC, Burns KEA, Rochwerg B. High-Flow Nasal Cannula Compared With Conventional Oxygen Therapy or Noninvasive Ventilation Immediately Postextubation: A Systematic Review and Meta-Analysis. Crit Care Med. 2020 Nov;48(11):e1129-e1136. doi: 10.1097/CCM.0000000000004576.
PMID: 32947472BACKGROUNDHernandez G, Vaquero C, Colinas L, Cuena R, Gonzalez P, Canabal A, Sanchez S, Rodriguez ML, Villasclaras A, Fernandez R. Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in High-Risk Patients: A Randomized Clinical Trial. JAMA. 2016 Oct 18;316(15):1565-1574. doi: 10.1001/jama.2016.14194.
PMID: 27706464BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lamees M Bakkar, Fellow
Fellow of Chest diseases Assiut University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical professor
Study Record Dates
First Submitted
December 20, 2022
First Posted
December 23, 2022
Study Start
October 1, 2021
Primary Completion
February 28, 2022
Study Completion
March 15, 2022
Last Updated
December 23, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share